The Translational Engine Powering Spatial Biology for Pharma 

Session details:

Spatial biology is rapidly entering pharma development programs, but its value is determined by whether it can change real decisions under clinical and operational constraints. This talk will focus on how PredxBio’s SpaceIQ™ platform is being deployed as a translational engine within pharma workflows - supporting patient stratification, biomarker development, and therapeutic decision-making in active drug programs. We’ll discuss how SpaceIQ™ integrates interpretable spatial analytics into discovery and clinical teams through close collaboration, enabling clearer links between tissue biology, mechanism of action, and patient outcomes. Real-world use cases will illustrate how this approach helps pharma teams move faster, reduce risk, and operationalize spatial biology at scale.